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Abstract
Background: The association between proinflammatory cytokine gene polymorphisms and gastric diseases related
to Helicobacter pylori varies by population and geographic area.
Our objective was to determine if the IL-1B -511 T>C and -31 C>T polymorphisms and H. pylori vacA genotypes are
associated with risk of chronic gastritis and gastric ulcer in a Mexican population.
Methods: We conducted endoscopic studies in 128 patients with symptoms of dyspepsia. We took two biopsies
from the body, antrum, or ulcer edge from each patient, and classified our histopathological findings according to
the Sydney System. H. pylori infection and vacA genotyping were accomplished via PCR from total DNA of the
gastric biopsies. We confirmed the presence of anti-H. pylori serum IgG and IgM in 102 control subjects. In both
case subjects and control subjects, the IL-1B -511 T>C polymorphism was genotyped by PCR-RFLPs and the IL-1B
-31 C>T polymorphism was genotyped by pyrosequencing.
Results: Sixty-two point seven (62.7%) of the 102 control subjects were H. pylori-seropositive. Among the case subjects,
100 were diagnosed with chronic gastritis and 28 with gastric ulcer. We found that 77% of the patients with chronic
gastritis and 85.7% of the patients with gastric ulcer were H. pylori-positive. The predominant H. pylori genotype was vacA
s1m1 (58.4%) and the most frequent subtype was vacA s1. The -511 TC, (rs16944 -511 T>C) genotype and the -511C allele
were associated with chronic gastritis (OR = 3.1, 95% CI = 1.4-6.8 and OR = 3.0, 95% CI = 1.4-6.0, respectively). The subjects
carrying -31T (rs1143627 -31 C>T) were found to be at a higher risk of having chronic gastritis (OR = 2.8, 95% CI = 1.3-5.8).
The IL-1B -511C/-31T haplotype was associated with chronic gastritis (OR = 2.1, 95% CI = 1.2-3.8) but not with gastric ulcer.
Conclusions: The H. pylori vacA genotypes identified herein were similar to those reported for other regions of
Mexico. The vacA s1m1 genotype was not associated with gastric ulcer. In the southern Mexican population, the
IL-1B -511C and -31T alleles and the -511C/-31T and -511T/-31T haplotypes are associated with increased risk of
chronic gastritis and gastric ulcer.
Background
Helicobacter pylori infection is related to the inflamma-
tory response of the gastric mucosa. While most infected
individuals remain asymptomatic, persistent colonization
and chronic inflammation increase the risk of developing
atrophic gastritis, peptic ulcers, and distal gastric adeno-
carcinoma [1]. The development of chronic gastritis is
the initiating event in the process that leads to stomach
cancer. The risk of malignancy increases with severity,
chronicity, and duration of the inflammatory process
[2,3]. Clinical outcome of H. pylori infection is deter-
mined by the genetic characteristics of the host and bac-
teria as well as environmental factors [4]. While H. pylori
is considered to be a class I carcinogen, it is accepted
that some genotypes have greater virulence. The strains
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that express cytotoxin-associated gene A (CagA) and
large quantities of vacuolating cytotoxin (VacA) are most
frequently found in patients with peptic ulcers and gas-
tric carcinoma [2,5,6]. It has been observed that H. pylori
vacA s1/m1 strains produce high levels of the cytotoxin,
strains s1/m2 produce moderate levels, and strains s2/m2
produce little or no toxin [7,9]. The vacA s1 subtype is
related to higher disease severity and a higher risk of
developing ulcers and stomach cancer [5,6,10].
H. pylori induce production of IL-1b in the gastric
mucosa. IL-1b modulates the expression of other proin-
flammatory cytokine genes such as TNF-a, IL-2, IL-6 and
IL-12, which increase the magnitude of inflammation [11].
The concentration of IL-1b produced by the inflamed
epithelium is influenced by two biallelic polymorphisms in
positions -511T>C (rs16944) and -31C>T (rs1143627).
These polymorphisms are in almost total genetic disequili-
brium, and -31 is a TATA-box polymorphism that signifi-
cantly affects DNA-protein interactions in vitro.
Thus, these single-nucleotide polymorphisms (SNPs) can
modulate production of IL-1b, directly affecting transcrip-
tion [12,13]. Given that IL-1b is a strong inhibitor of
gastric acid secretion and may contribute to dispersion of
H. pylori from the pylorus to the corpus of the stomach,
polymorphisms in the IL-1b gene can be considered a
key genetic factor in determining the pattern of gastritis
that develops and one risk of malignant transformation
[13,14]. The IL-1B -511T and -31C alleles are associated
with high levels of the cytokine and with severe inflamma-
tion or stomach cancer, in comparison to -511C and
-31T, which are associated with low levels of IL-1b.
This association with H pylori infection or stomach
cancer has not been significant in all populations
[2,4,6,11,13-20].
In combination, bacterium virulence factors and IL-B
polymorphisms (cagA+/vacA+/IL-1B-511T/IL-RN*2) are
associated with severe histological changes in the gastric
mucosa of some populations [1,4]. However, the varia-
bility of results across populations and geographic areas
has been a source of ongoing controversy [2,13,14].
While gastritis, ulcer, and duodenitis constitute the
fourth leading cause of disease in the Mexican popula-
tion [21], the genetic basis for inter-individual variations
in inflammatory response and cytokine production, in
the context of H. pylori infection, has not been well stu-
died in the Mexican population.
Genotyping of H. pylori vacA and IL-1B polymorph-
isms could be important in the early identification of
individuals at high risk for developing severe gastric dis-
eases. The objective of this study was to evaluate the
relationship between IL-1B -511 T>C and -31 C>T poly-
morphisms and the presence of chronic gastritis and
gastric ulcer, and to analyze the relationship of H. pylori
vacA genotypes with gastric ulcer.
Methods
Population
We studied 128 patients subjected to an endoscopic
study in the Specialized Unit for Gastroenterology Endo-
scopy in the city of Chilpancingo, in the state of Guer-
rero, Mexico, from April 2007 to May 2008. All subjects
suffered from functional dyspepsia, epigastric pain, and
ulcerative syndrome. Patients who had not received
H. pylori erradication therapy, and had not been treated
with proton pump inhibitors nor with gastric pH neu-
tralizers during the two months prior to the endoscopy
were included in the study. We also studied 102 subjects
without dyspepsia symptoms, from the same population
as the cases, with no history of H. pylori infection or
gastroduodenal diseases. In both groups, we excluded
subjects under non-steroidal anti-inflammatory drug
(NSAID) treatment.
Informed consent was obtained from participants or
their parents. Participants’ eating habits, socio-demo-
graphic factors, family history of gastritis or ulcers, alco-
hol consumption, and smoking habits were recorded via
surveys. The study was approved by the Bioethics Com-
mittee of the Universidad Autónoma de Guerrero.
Endoscopy and gastric histology
For each patient, endoscopy was carried out using a
video processor and video gastroscope (Fujinon, Wayne,
NJ, USA). From each patient, we took two biopsies from
the antrum, corpus, or ulcer edge; one specimen was
immediately fixed in formalin for histological testing
and the other was placed in buffer solution (Tris
10 mM pH 8.0, EDTA 20 mM pH 8.0, SDS 0.5%) for
H. pylori diagnosis. The biopsies intended for H. pylori
detection were kept at -20°C until processing. The histo-
logical sections were stained with hematoxylin-eosin and
evaluated by a pathologist using the updated Sydney
System criteria [22]. Endoscopic observation and histo-
pathological confirmation were used to determine
patient pathology.
Serology
Blood samples (5 ml) were taken from all control sub-
jects. The serum was tested for IgG and IgM anti-H.
pylori by enzyme-linked immunosorbent assay (ELISA;
International Immuno-Diagnostics, Foster City, CA,
USA) according to the manufacturer’s instructions. The
sensitivity and specificity of this method are 96% and
97%, respectively. A subject was considered H. pylori-
positive if we detected at least one of the two antibodies.
H. pylori detection and vacA genotyping
Total DNA was extracted from the gastric biopsies of
each patient via the phenol:chloroform:isoamilic alcohol
technique, after digestion with proteinase K [23].
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In the cases, the presence of H. pylori was detected by
polymerase chain reaction (PCR) for the 16S rRNA gene.
We used 150 ng total DNA, 2.5 mM MgCl2, 0.2 mM
dNTPs (Invitrogen, Carlsbad, CA, USA), 10 pmol of each
oligonucleotide, and 1 U Platinum®Taq DNA Polymerase
(Invitrogen, Carlsbad, CA, USA) in a final volume of
15 μL. The H. pylori-positive samples were subjected to
detection of subtypes of vacA by PCR. For PCR of the
signal region (s) and medium (m), we used 300 ng total
DNA, 1.5 mM MgCl2, 0.2 mM dNTP, 15 pmol of each
oligonucleotide, and 1 U Platinum®Taq DNA Polymerase
in a final volume of 20 μL. The amplification protocols
were previously described by Atherton et al. and Park et
al. [24,25]. In each PCR, we used DNA from strain
ATCC43504, vacA s1/m1 as positive control for H. pylori
and for vacA genotypes. The template DNA was substi-
tuted with sterile deionized water in the negative control.
All PCRs were conducted in a Mastercycler® Ep gradient
thermal cycler (Eppendorf, Hamburg, Germany).
IL-1B -511 T>C and -31 C>T genotyping
We obtained peripheral blood DNA from the control
subjects using Miller’s technique [26]. Genotyping of the
IL-1B -511 T>C SNP was done via PCR-restriction frag-
ment length polymorphism (RFLP) as previously
described [1]. Eight-microliter of PCR product were
digested with 2 U AvaI (New England Biolabs, Ipswich,
MA, USA) at 37°C for 12 h and analyzed in 2% agarose
gels. The IL-1B -31 C>T SNP was genotyped by pyrose-
quencing, following the methodology described by Pérez
et al. [27]. Of the 230 samples processed, 12% were sub-
jected to PCR-RFLP for genotype verification.
Statistical Analysis
We applied X2 or Fisher’s exact test to compare frequen-
cies between groups, and analysis of variance (ANOVA)
or Kruskal-Wallis tests to compare means and medians,
respectively. In the control group, we evaluated the
Hardy-Weinberg Equilibrium (HWE) for IL-1B poly-
morphisms. To determine the association of IL-1B poly-
morphisms with chronic gastritis and gastric ulcer, we
evaluated binomial and polynomial logistic regression
models, and used multiplicative interaction models to
study the effect of possible interactions between H. pylori
and IL-1B genotypes and gastric ulcer. We calculated
Lewontin’s D’ statistic for linkage disequilibrium between
loci. Two-tailed statistical tests were conducted with a
significance level of 5% using STATA 10 software.
Results
Histological diagnosis
Of the 128 patients examined, 78.1% had chronic gastri-
tis and 21.9% had gastric ulcer. The majority of cases
and controls were women. The average age was 29 years
for controls (range 17-61), 46 years for chronic gastritis
cases (range 11-80), and 56 years for gastric ulcer
patients (range 25-83). There were significant differences
among the three groups in age, years of schooling, geo-
graphic origin, family history of gastritis or ulcer, and
smoking habits (p < 0.05), table 1.
H. pylori infection and vacA genotypes
In 64/102 (62.7%) control subjects anti-H. pylori antibo-
dies were detected; 47 control subjects (46.1%) were
positive for either IgG or IgM and 17 (16.7%) were IgG
+/IgM+. Of the 128 cases, 101 (78.9%) were H. pylori-
positive, and the prevalence varied by diagnosis. One
vacA genotype was detected in 85/101 (84.2%) infected
subjects and two genotypes were detected in 15/101
(14.8%) subjects. The s1m1 genotype was detected in
59/101(58.4%) infected subjects, s1m2 was detected in
37/101 (36.6%), s2m2 in 19/101 (18.8%), and s1m1/s1m2
in 15/101 (14.8%) infected subjects. One sample did not
amplify for m subtypes. Genotypes s1m1 and s1m2 were
predominant in the two groups of cases, table 2. Most,
97/116 (83.6%), typed subtypes were vacA s1. The s1var-
iant was detected in 22/25 (88%) of the patients with
ulcer and 75/91(82.4%) of those with gastritis. Co-infec-
tion with s1m1/s1m2 genotypes was more frequent in
patients with chronic gastritis (18.2%) than in those with
gastric ulcer (4.2%).There was not significant association
between the H. pylori s1 subtype and gastric ulcer (OR
= 1.9, 95%CI = 0.29-12.8, p = 0.48) as compared to
chronic gastritis. H. pylori infection was associated with
chronic gastritis (OR = 2.3, 95%CI = 1.2-4.1, p = 0.009)
and with gastric ulcer (OR = 4.0, 95%CI = 1.3-12.5, p =
0.016) as compared to controls.
IL-1B -511 T>C and -31 C>T polymorphisms
In the control group, the -511 T>C and -31 C>T IL-1B
SNPs genotypes were in Hardy-Weinberg equilibrium
(HWE) (for SNP -511 X2 = 0.500, p = 0.479; for SNP
-31 X2 = 0.014, p = 0.905). The genotypic frequencies of
the IL-1B -511 T>C and -31 C>T SNPs were signifi-
cantly different between the patient and control groups
(-511 T>C, p = 0.015; -31 C>T, p = 0.027). For rs16944
(-511 T>C), the frequency of genotype TC was greater
in patients with gastritis (60%) and ulcer (46.4%) than in
control subjects (38.2%). Genotype CC was the most fre-
quent in patients with gastric ulcer (17.9%). The geno-
type frequency distribution for rs1143627 (-31 C>T) CT
was 57.1% among patients with gastric ulcer, 52%
among patients with chronic gastritis, and 41.2% among
controls. Genotype TT was more frequent in individuals
with gastritis. The IL-1B -31T allele was the most fre-
quent among patients with chronic gastritis and ulcer
compared to control subjects, table 3. Concordance of
results between pyrosequencing and PCR-RFLP
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genotyping of -31 C>T SNP was 96.4%. Linkage disequi-
librium was almost complete between IL-1B-31 and IL-
1B-511 in the case subjects (D’ = 0.97; p < 0.001).
The -511TC/-31CT genotypes were more frequent
among patients with chronic gastritis (48%) and patients
with gastric ulcer (42.9%); in contrast, the -511TT/-
31CC combination was present in 29% and 32.1% of
these groups, respectively. CT/TT of IL-1B -31 C>T
SNP was associated with the presence of chronic gastri-
tis (OR = 2.8, 95% CI = 1.3-5.8, p = 0.006) but not with
the presence of gastric ulcer, table 4. Adjusting for age,
place of origin, schooling, smoking habits, family history
of gastritis or gastric ulcer, and H. pylori infection, TC/
CC of IL-1B -511 T>C SNP was significantly associated
Table 1 Socio-demographic characteristics in cases and controls
Cases
Characteristic Controls
(n = 102)
Chronic gastritis
(n = 100)
Gastric ulcer
(n = 28)
p-value
Age (mean ± sd; years) 29.8 ± 11 46.1 ± 14.6 56.3 ± 17.1 <0.001€
Gender n(%)
Female 65 (63.7) 64 (64) 19 (67.9) 0.917 θ
Male 37 (36.3) 36 (36) 9 (32.1)
Education [mean (range); years] 12 (12-17) 12 (6-17) 6 (0-12) <0.001†
Geographical area n(%)
Chilpancingo 44 (43.1) 30 (30) 5 (17.9) 0.021 θ
Other municipalities 58 (56.9) 70 (70) 23 (82.1)
Family history of gastritis and/or ulcer n(%) 0.001 θ
No 49 (48.0) 39 (39.0) 22 (78.6)
Yes 53 (52.0) 61 (61.0) 6 (21.4)
Smoking habit n(%)
No 39 (38.2) 65 (65) 10 (35.7) <0.001θ
Current smoker or former smoker 63 (61.8) 35 (35) 18 (64.3)
Alcohol consumption n(%)
No 14 (13.7) 22 (22) 7 (25) 0.211 θ
Consumes or consumed 88 (86.3) 78 (78) 21 (75)
€ ANOVA test; † Kruskal-Wallis test; θ X2 Test; Ω Fisher’s exact test.
Table 2 Genotype and alleles of H. pylori vacA
frequencies in cases
Genotypes or alleles Cases p-value
Chronic gastritis
n(%)
Gastric ulcer
n(%)
Genotypes
s1m1 31 (40.2) 13 (54.1) 0.254Ω
s1m2 16 (20.8) 6 (25.0)
s2m2 16 (20.8) 3 (12.5)
s1m1 y s1m2 14 (18.2) 1 (4.2)
Not typed * - 1 (4.2)
Total 77 (100) 24 (100)
Alleles s
s1 75 (82.4) 22 (88.0) 0.551Ω
s2 16 (17.6) 3 (12.0)
Total 91 (100) 25 (100)
Alleles m
m1 45 (49.5) 14 (58.3) 0.187θ
m2 46 (50.5) 10 (41.7)
Total 91 (100) 24♪ (100)
*Signal region s1genotype Ω Fisher’s exact test θ X2 Test.
♪It was not possible to amplify the m allele in one biopsy.
Table 3 Genotypic distribution and allelic frequencies of
IL-1B polymorphisms in cases and controls
Cases
511 T>C SNP Controls
n (%)
Chronic gastritis
n (%)
Gastric ulcer
n (%)
p-value
Genotype
TT 53 (52.0) 31 (31.0) 10 (35.7) 0.015θ
TC 39 (38.2) 60 (60.0) 13 (46.4)
CC 10 (9.8) 9 (9.0) 5 (17.9)
Allele
T 0.711 0.610 0.589 0.060θ
C 0.289 0.390 0.411
-31 C>T SNP
Genotype
CC 52 (51.0) 31 (31.0) 10 (35.7) 0.027Ω
CT 42 (41.2) 52 (52.0) 16 (57.1)
TT 8 (7.8) 17 (17.0) 2 (7.1)
Allele
C 0.716 0.570 0.643 0.009θ
T 0.284 0.430 0.357
θ X2 Test Ω Fisher’s exact test
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with ulcer and chronic gastritis together, as compared to
controls (OR = 2.9, 95% CI = 1.4-5.8, p = 0.004). Separ-
ating by diagnosis, we found association of -511TC/CC
with chronic gastritis (OR = 3.0, 95%CI = 1.4-6.3, p =
0.003). The -511C/-31T and -511T/-31T haplotypes
were significantly associated with chronic gastritis but
not with gastric ulcer, table 5.
To determine whether carriers of -511C and -31T
alleles who were infected by H. pylori vacA s1 showed
higher risk of gastritis or ulcer, the OR was calculated
for the patients exposed to H. pylori vacA s1 within
each group, as compared to those infected with H.
pylori vacA s2. We did not observe significant associa-
tion between infection with H. pylori vacA s1 with
chronic gastritis or gastric ulcer in carriers of the IL-
1B-511C and -31T alleles or their haplotypes (data not
shown).
Discussion
In patients with chronic gastritis, we only found geno-
types vacA s1m1, s1m2, and s2m2. However the most
virulent allele, vacAs1, was the most frequent in patients
with both diseases. Our results agree with those
reported by other authors and confirm that the s1m1ge-
notype is in greatest circulation in Mexico [28-30]. The
lack of significant association between vacA s1m1with
gastric ulcer, as compared to chronic gastritis, may be
explained by the presence of multiple factors giving rise
to the disease and by the small sample size in our study.
Chronic infection with H. pylori induces hypochlorhy-
dria, and this is a critical factor in the development of
gastric pathology. Thus, the genetic factors in the host
that influence acid secretion can also mediate the clini-
cal progress of H. pylori infection. IL-1b is a powerful
proinflammatory cytokine that is overexpressed in the
presence of H. pylori and plays an important role in
amplifying the inflammatory response to the infection
[1,6,31,32]. The biallelic polymorphisms in positions -31
and -511 of IL-1B influence cytokine expression; allele T
in position -31 forms a TATA-Box that can potentiate
and induce expression of IL-1b [32,33]. It has been
reported that the IL-1B -511T/IL-1B-31C alleles are sig-
nificantly associated with the development of hypochlor-
hydria, H. pylori infection, gastritis, and stomach cancer,
however the variability of results from studies conducted
in various populations remain controversial [33-36].
Interestingly, in our study, the -511 TC/CC and -31
CT/TT IL-1B genotypes were associated with the pre-
sence of chronic gastritis and the presence of gastric
ulcer when all cases were grouped (-511 TC/CC OR
adjusted = 2.8, 95% CI = 1.6-5.1; -31 CT/TT OR adjusted =
2.9, 95% CI = 1.6-5.3). Greater risk of chronic gastritis
and stomach cancer has also been reported in Japanese
population with the -511CC genotype and in Chinese
Table 4 Association of IL-1B polymorphisms with chronic gastritis and gastric ulcer
SNP Model Genotype Gastritis Ulcer
OR (95%CI) p-value OR (95%CI) p-value
-511 T>C Co-dominant TT 1.0* 1.0*
TC 3.1 (1.4-6.8) 0.004 2.3 (0.7-7.6) 0.175
CC 2.5 (0.7-8.4) 0.148 5.0 (0.9-29.0) 0.075
Dominant TT 1.0* 1.0*
TC/CC 3.0 (1.4-6.3) 0.003 2.6 (0.8-8.2) 0.094
-31C>T Co-dominant CC 1.0* 1.0*
CT 2.3 (1.1-5.0) 0.035 2.6 (0.8-8.8) 0.112
TT 5.6 (1.8-17.6) 0.003 1.6 (0.2-12.6) 0.667
Dominant CC 1.0* 1.0*
CT/TT 2.8 (1.3-5.8) 0.006 2.5 (0.8-7.9) 0.122
* Reference category: healthy individuals. Models adjusted by age, place of origin, education, smoking habit, family history of gastritis or gastric ulcer, and H.
pylori infection.
Table 5 Haplotypes of IL-1B SNPs and their association with gastritis and gastric ulcer
Haplotype SNP Controls Cases
-511 -31 Chronic gastritis OR (95%CI) p-value Gastric ulcer OR (95%CI) p-value
1 T C 0.706 0.543 1.0* 0.570 1.0*
2 C T 0.279 0.363 2.1 (1.2-3.8) 0.02 0.338 1.3 (0.2-7.5) 0.97
3 T T 0.005 0.067 16 (1.2-221) 0.04 0.019 ID
4 C C 0.010 0.027 3 (0.4-24.6) 0.31 0.073 ID
ID: insufficient data. * Reference category. Models adjusted by age, place of origin, education, smoking habit, family history of gastritis or gastric ulcer, and
H. pylori infection.
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population with the CT genotype [37]. In the Thai
population, IL-1B genotype -511CC is considered a risk
factor for stomach cancer [38]. A previous study in a
Japanese population showed that subjects with the
-31TT genotype had a significantly higher risk of H.
pylori infection (OR= 1.74, 95% CI = 1.15-5.63) than
subjects with -31CT or -31CC genotypes. A similar
result was obtained for H. pylori-seropositive Japanese-
Brazilians (OR -31TT = 1.45, 95% CI = 1.02-2.07)
[13,39]. In a Korean population, the -31T polymorphism
was found to be associated with stomach cancer [33];
and in Polish and Western Scottish populations, the
-31T allele was found to be associated with both H.
pylori infection and hypochlorhydria as well as a higher
risk of stomach cancer [32]. In a Spanish population,
García-González et al. found that IL-1B -511 C/-31 T
contributed to risk of duodenal ulcer [40].
In our study, the effect of the -31CT/TT and -511TC/
CC genotypes on risk of chronic gastritis was greater
when we adjusted for factors such as age, place of ori-
gin, schooling, smoking habits, family history of gastritis
or gastric ulcer, and H. pylori infection. Therefore, the
habits and lifestyles of the studied individuals modified
the risk of developing chronic gastritis. Such findings
support the multifactorial model of gastric pathology
that includes the host, H. pylori, and the environment
[13,36,39]. Given the OR values, it is likely that the
same is true for gastric ulcer, but due to the small size
of the sample it was not possible to obtain significant
associations.
To our knowledge, this is the first study to examine
the association of -511 T>C and -31 C>T SNPs in Mex-
ican patients with chronic gastritis and gastric ulcer.
Two prior studies found that the -31CC genotype was
associated with stomach cancer as compared to the
-31TT genotype (in the northeast region of Mexico, OR
= 7.6, 95% CI = 1.73-46.9; in the southeast and central
regions of Mexico, OR = 3.19, 95% CI = 1.05-9.68)
[6,41]. These differences might be the result of genomic
diversity in the populations across different regions of
Mexico. The sub-population in the northern region of
Mexico has a greater contribution of European ancestry,
while the population of Guerrero has a particularly
dominant African ancestral contribution, with a minor
European contribution and is genetically closer to the
Zapotecs [42].
Chronic gastritis and gastric ulcer are part of the nat-
ural evolution to stomach cancer [3,4], and it is possible
that a similar phenomenon occurs in Mexico as has
been observed in Asian populations, in which the distri-
bution of IL-1B genotypes differs between the northern
region, where there is a high prevalence of stomach can-
cer, and the southern region, where there is a low preva-
lence of stomach cancer [33-35,43].
The information available on IL-1B alleles associated
with diseases linked to H. pylori is controversial. While
some researchers have found that IL-1B -511TT and IL-
1B -31CC are proinflammatory [32,44], others have
found, with in vitro experiments and with stomach can-
cer patients infected with H. pylori, that the IL-1B
-511C and IL-1B -31T alleles potentiate expression of
IL-1b in the gastric mucosa [33,45,46]. The results of
our work agree with those of Takagi et al. who found
that the IL-1B -511CC/IL-1B -31TT genotypes potenti-
ate cytokine production and are significantly associated
with the clinical development of H. pylori infection [47].
Conclusions
Patients with chronic gastritis and gastric ulcer were
infected predominantly with H. pylori vacA s1m1 geno-
type and the vacAs1 allelotype was the most frequent.
In chronic gastritis the s1m1 y s1m2 genotypes tend to
be associated in co-infections.
In the population of southern Mexico, -511C or -31T
alleles and -511C/-31T or -511T/-31T haplotypes of IL-
1B increase the risk of chronic gastritis and gastric ulcer.
The results of this study support the hypothesis that the
combined effect of lifestyle, infection with virulent genotypes
of H. pylori, and genetic factors of the host, such as IL-1B
-511C/IL-1B -31T polymorphisms, can play an important
role in development of chronic gastritis and gastric ulcer in
the Mexican population of the state of Guerrero.
Acknowledgements
The authors wish to thank Elizabeth Rosales-Cruzaley as well as the nurses
and support personnel of the Gastroenterologic Endoscopy Specialized Unit
of Chilpancingo, who assisted in obtaining samples. We also want to thank
Martín O. Morrugares Ixtepan, Specialist in Pathological Anatomy with
subspecialty in Oncological Pathology, who was responsible for the
histopathological diagnosis. The study was financed by the Secretaría de
Educación Pública, via PIFI 2007 and the Programa de Apoyo a la
Reincorporación de Exbecarios PROMEP 2007, key PROMEP UAGUER-EXB-
096. During our study, Dinorah Nashely was a grant recipient of the Consejo
Nacional de Ciencia y Tecnología de México. Finally, we would like to thank
Dinorah Leyva-Illades (Texas A&M Health Science Center) for translating this
manuscript to the English language.
Author details
1Laboratorio de Investigación Clínica, Unidad Académica de Ciencias
Químico Biológicas, Universidad Autónoma de Guerrero. Av. Lázaro Cárdenas
S/N. Ciudad Universitaria, Colonia Haciendita, Chilpancingo, Guerrero. C.P.
39090, México. 2Departamento de Microbiología, Facultad de Medicina,
Universidad Autónoma de Nuevo León. Av. Madero y Dr. Aguirre S/N,
Colonia Mitras Centro, Monterrey N. L. C. P. 64460 México. 3Unidad
Especializada en Gastroenterología Endoscopia. Privada de Jacarandas No. 5,
Col. Residencial Bugambilias, Chilpancingo, Guerrero, C.P. 39090 México.
4Laboratorio de Enfermedades Crónico Degenerativas, Unidad Académica de
Ciencias Químico Biológicas de la Universidad Autónoma de Guerrero.
Chilpancingo, Guerrero, México. 5Laboratorio de Biomedicina Molecular,
Unidad Académica de Ciencias Químico Biológicas de la Universidad
Autónoma de Guerrero. Chilpancingo, Guerrero, México.
Authors’ contributions
All authors read and approved the final study. GFT designed and
coordinated the study and wrote the draft. DNMC optimized the PCR
Martínez-Carrillo et al. BMC Gastroenterology 2010, 10:126
http://www.biomedcentral.com/1471-230X/10/126
Page 6 of 8
conditions, carried out molecular analysis and descriptive analysis of the
data, and contributed in preparation of the study. EGG directed
pyrosequencing and participated in study preparation. EFA conducted
statistical data analysis, RBL recruited patients and carried out the
endoscopies on gastric biopsies, TMM conducted surveys and carried out
PCR, CAR did ELISA and participated in conducting surveys, BIA participated
in study design and data analysis, ARR participated in study design and
coordination.
Competing interests
The authors declare that they have no competing interests.
Received: 20 April 2010 Accepted: 27 October 2010
Published: 27 October 2010
References
1. Rad R, Prinz C, Neu B, Neuhofer M, Zeitner Voland P, Becker I, Schepp W,
Gerhard M: Synergistic effect of Helicobacter pylori virulence factors and
interleukin-1 polymorphisms for the development of severe histological
changes in the gastric mucosa. JID 2003, 188:272-280.
2. Sierra R, Une C, Ramírez V, Alpízar-Alpízar W, González MI, Ramírez JA, De
Mascarel A, Cuenca P, Pérez-Pérez G, Mégraud F: Relation of atrophic
gastritis with Helicobacter pylori-CagA+ and interleukin-1 gene
polymorphisms. World J Gastroenterol 2008, 14:6481-6487.
3. Fox JG, Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest
2007, 117:60-69.
4. Peek RM, Blaser MJ: Helicobacter pylori and gastrointestinal tract
adenocarcinomas. Nature 2002, 2:28-37.
5. Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H: The Helicobacter pylori
duodenal ulcer promoting gene, dupA in China. BMC Gastroenterology
2008, 8:49.
6. Garza-González E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-
Menchaca R, Maldonado-Garza HJ, Pérez-Pérez GI: Role of the polymorphic
IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J
Cancer 2005, 114:237-241.
7. Marciorkowska E, Roszko I, Kowalczuk O, Kaczmarski M, Chyczewski L,
Kemona A: The evaluation of vacA gene allele frequency in Helicobacter
pylori strains in adults and children in Podlaskies region. Folia Histochem
Cytobiol 2007, 45:215-219.
8. Caricio-Martins L, Oliveira-Corvelo TC, Demachki S, Araujo MTF, Baraúna-
Assumpção M, Araujo-Jucá Vilar SC, Bonfim-Freitas F, Melo-Barbosa HP,
Alves-Fecury A, Kelly-Costa do Amaral R, Batista-dos Santos SE: Clinical and
pathological importance of vacA allele heterogeneity and cagA status in
peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz
2005, 100:875-881.
9. Chang YH, Wang L, Lee MS, Cheng CW, Wu CY, Shiau MY: Genotypic
characterization of Helicobacter pylori cagA and vacA from biopsy
specimens of patients with gastroduodenal diseases. Mt Sinai J Med
2006, 73:622-626.
10. Garza-González E, Bocanegra-García V, Bosques-Padilla FJ, Flores-
Gutiérrez JP, Moreno F, Perez-Perez GI: mRNA levels of TLR4 and TLR5 are
independent of H pylori. World J Gastroenterol 2008, 14:5306-5310.
11. Moorchung N, Srivastava AN, Gupta NK, Ghoshal UC, Achyut BR, Mittal B:
Cytokine gene polymorphisms and the pathology of chronic gastritis.
Singapore Med J 2007, 48:447-454.
12. Kim SH, Mok JW, Kim HS, Joo CK: Association of -31T>C and -511 C>T
polymorphisms in the interleukin 1 beta IL1B) promoter in Korean
keratoconus patients. Mol Vis 2008, 14:2109-2116.
13. Uno M, Hamajima N, Ito LS, Oba S, Marie SKN, Shinjo SK, Onda H, Saito T,
Takezaki T, Tajima K, Tominaga S: Helicobacter pylori seropositivity and IL-
1B C-31T polymorphism among Japanese Brazilians. Int J Mol Med 2002,
10:321-326.
14. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N:
Association of the interleukin-1β genetic polymorphism and gastric
cancer risk in Japanese. J Gastroenterol 2001, 36:696-9.
15. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2
(IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J
Immunol 1998, 47:195-198.
16. Hsu PI, Li CN, Tseng HH, Lai KH, Hsu PN, Lo GH, Lo CC, Yeh JJ, Ger LP,
Hsiao M, Yamoaka Y, Hwang IR, Chen A: The Interleukin-I RN
polymorphism and Helicobacter pylori infection in the development of
duodenal ulcer. Helicobacter 2004, 9:604-613.
17. Al-Moundhri MS, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A,
Ganguly SS, Al-Yahyaee SA, Grant CS: Interleukin-1β gene (IL-1B) and
interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and
gastric cancer risk in an Omani Arab population. Gastric Cancer 2006,
9:284-290.
18. El-Omar EM: The importance of interleukin 1β in Helicobacter pylori
associated disease. Gut 2001, 48:743-747.
19. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R,
Capelinha AF, Quint W, Caldas C, van Dooorn LJ, Carneiro F, Sobrinho-
Simoes M: Helicobater pylori and Interleukin 1 genotyping: An
opportunity to identify high-risk individuals for gastric carcinoma. J Natl
Cancer Inst 2002, 94:1680-1686.
20. Pérez-Pérez GI, Garza-González E, Portal C, Olivares AZ: Role of cytokine
polymorphisms in the risk of distal gastric cancer development. Cancer
Epidemiol Biomarkers Prev 2005, 14:1869-73.
21. Secretaría de Salud, Subsecretaría de Prevención y Promoción de la Salud.
Centro Nacional de Vigilancia Epidemiológica y Control de Enfermedades.
Dirección General de Epidemiología: Información epidemiológica de
morbilidad. México 2006.
22. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of
gastritis. The updated Sydney system-International workshop on the
histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996,
20:1161-1181.
23. Sambrook J, Russel D: Molecular Cloning a Laboratory Manual EU: Col Spring
Harbor Laboratory Press; 2001.
24. Atherton JC, Cao P, Peek RMR Jr, Tummuru MKR, Blasser MJ, Cover TL:
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol
Chem 1995, 270:17771-17777.
25. Park CY, Kwak M, Gutierrez O, Graham DY, Yamaoka Y: Comparison of
genotyping Helicobacter pylori directly from biopsy specimens and
genotyping from bacterial cultures. J Clin Microbiol 2003, 41:3336-3338.
26. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for
extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
27. Pérez-Pérez GI, Portal-Celhay C, Bosques-Padilla FJ, Garza-González E:
Desarrollo de un protocolo de pirosecuenciación para la tipificación del
polimorfismo -31 del gen de la interleucina 1β en el estudio del riesgo
al desarrollo de cáncer gástrico. Rev Gastroenterol Mex 2007, 72:136-140.
28. Morales-Espinoza R, Castillo-Rojas G, Gonzalez-Valencia G, Ponce-DeLeon S,
Cravioto A, Atherton JC, López-Vidal Y: Colonization of Mexican patients
by multiple Helicobacter pylori strains with different vacA and cagA
genotypes. J Clin Microbiol 1999, 3001-3004.
29. Garza-González E, Bosques-Padilla FJ, Tijerina-Menchaca R, Pérez-Pérez GI:
Characterisation of Helicobacter pylori isolates from the north-eastern
region of Mexico. Clin Microbiol Infect 2004, 10:41-45.
30. Paniagua GL, Monroy E, Rodríguez R, Arroniz S, Rodríguez C, Cortés JL,
Camacho A, Negrete E, Vaca S: Frequency of vacA, cagA and babA2
virulence markers in Helicobacter pylori strains isolated from Mexican
patients with chronic gastritis. Ann Clin Microbiol Antimicrob 2009, 8:14.
31. Ruzzo A, Graziano F, Pizzagalli F, Santini D, Battistelli V, Panunzi S,
Canestrari E, Catalano V, Humar B, Ficarelli R, Bearzi I, Cascinu S, Naldi N,
Testa E, Magnani M: Interleukin 1B gene (IL-1B) and interleukin 1
receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-
negative gastric cancer of intestinal and diffuse histotype. Ann Oncol
2005, 16:887-92.
32. El-Omar EM, Carrington M, Chow WH, McColl KE, Breamk JH, Young HA,
Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M,
Fraumeni JF, Rabkin CS: Interleukin-1 polymorphisms associated with
increased risk of gastric cancer. Nature 2000, 404:398-402.
33. Chang YW, Jang JY, Kim NH, Won-Lee J, Jung-Lee J, Won-Jung W,
Dong SH, Kim HJ, Kim BH, Lee JI, Chang R: Interleukin-1B (IL-1B)
polymorphisms and gastric mucosal levels of IL-1β cytokine in Korean
patients with gastric cancer. Int J Cancer 2005, 114:465-471.
34. Kamangar F, Cheng C, Abnet CC, Rabkin CS: Interleukin-1B polymorphisms
and gastric cancer risk–a meta-analysis. Cancer Epidemiol Biomarkers Prev
2006, 15:1920-8.
35. Prinz C, Schwendy Voland P: H. pylori and gastric cancer: Shifting the
global burden. World J Gastroenterology 2006, 12(Suppl 34):5458-5464.
36. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Sata F, Sato H, Kishi R: H pylori
Martínez-Carrillo et al. BMC Gastroenterology 2010, 10:126
http://www.biomedcentral.com/1471-230X/10/126
Page 7 of 8
seropositivity and cytokine gene polymorphisms. World J Gastroenterol
2007, 13:4445-4451.
37. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T,
Yamada N: Genetic differences in interleukin-1 beta polymorphisms
among four Asian populations: An analysis of the Asian paradox
between H. pylori infection and gastric cancer incidence. J Exp Clin
Cancer Res 2003, 22:47-55.
38. Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S,
Matsukura N: Helicobacter pylori infection in combination with the serum
pepsinogen I/II ratio and interleukin-1b-511 polymorphisms are
independent risk factors for gastric cancer in Thais. J Gastroenterol 2006,
41:1169-1177.
39. Katsuda N, Hamajima N, Tamakoshi A, Wakai K, Matsuo K, Saito T, Tajima K,
Tominaga S: Helicobacter pylori seropositivity and the myeloperoxidase
G-463A polymorphism in combination with interleukin-1B C-31T in
Japanese health checkup examinees. Jpn J Clin Oncol 2003, 33:192-197.
40. García-González MA, Lanas A, Savelkoul PHM, Santolaria S, Benito R,
Crusius JBA, Peña AS: Association of interleukin 1 gene family
polymorphisms with duodenal ulcer disease. Clin Exp Immunol 2003,
134:525-531.
41. Sicinschi LA, López-Carrillo L, Camargo MC, Correa P, Sierra RA, Henry RR,
Jia C, Zabaleta J, Piazuelo MB, Schneider BG: Gastric cancer risk in a
Mexican Population: Role of Helicobacter pylori cagA positive infection
and polymorphisms in interleukin-1 and -10 genes. Int J Cancer 2006,
118:649-657.
42. Silva-Zolezzi I, Hidalgo Miranda A, Estrada Gil1 J, Fernández López JC, Uribe
Figueroa L, Contreras A, Balam Ortiz E, del Bosque Plata L, Lara C, Velázquez
Fernández D, Goya R, Hernández Lemus E, Dávila C, Barrientos E, March S,
Jiménez-Sánchez G: Análisis de la diversidad genómica en las
poblaciones mestizas mexicanas para desarrollar medicina genómica en
México. Proc Natl Acad Sci U S A. 2009, 106(21):8611-8616.
43. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H:
Interleukin 1beta polymorphisms increase risk of hypochlorhydria and
atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
Gastroenterology 2002, 123:92-105.
44. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY,
Yamaoka Y: Effect of interleukin 1 polymorphisms on gastric mucosal
interleukin 1β production in Helicobacter pylori infection. Gastroenterology
2002, 123:1793-803.
45. Chakravortya M, Datta D, Choudhuryb A, Roychoudhurya S: IL1B promoter
polymorphism regulates the expression of gastric acid stimulating
hormone gastrin. Int J Biochem Cell Biol 2009, 41:1502-1510.
46. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJY: Association of
interleukin 1B gene polymorphisms and gastric cancers in high and low
prevalence regions in China. Gut 2003, 52:1684-9.
47. Takagi A, Deguchi R, Kobayashi K, Miwa T: Cytokine expressions and H.
pylori-associated gastric mucosal lesion. Keio J Med 2002, 51(Suppl
2):51-2.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-230X/10/126/prepub
doi:10.1186/1471-230X-10-126
Cite this article as: Martínez-Carrillo et al.: Association of IL1B -511C/-31T
haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and
chronic gastritis. BMC Gastroenterology 2010 10:126.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Martínez-Carrillo et al. BMC Gastroenterology 2010, 10:126
http://www.biomedcentral.com/1471-230X/10/126
Page 8 of 8
